Crizalk 250 mg Capsule Crizalk 250 mg Capsule Crizalk 250 mg Capsule Crizalk 250 mg Capsule Crizalk 250 mg Capsule

Crizalk 250 mg Capsule

84375.0 INR/STRIP

Product Details:

  • Origin of Medicine United States of America
  • Physical Form Capsules
  • Recommended For DOCTOR
  • Quantity 3 Strip
  • Click to view more
X

Crizalk 250 mg Capsule Price And Quantity

  • 3 Box
  • 84375.0 INR/STRIP

Crizalk 250 mg Capsule Product Specifications

  • DOCTOR
  • 3 Strip
  • United States of America
  • Capsules

Crizalk 250 mg Capsule Trade Information

  • 1 Week

Product Description

Crizalk 250 mg capsules are a targeted anticancer therapy containing crizotinib, specifically designed to combat anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) that is locally advanced or has metastasized beyond the lungs. This medication is particularly beneficial for patients whose tumors have been confirmed as ROS1-positive, offering a vital treatment option in challenging cases of metastatic NSCLC. Crizotinib works by inhibiting the abnormal proteins that contribute to tumor growth, effectively slowing disease progression and improving patient outcomes. While Crizalk can provide significant therapeutic benefits, it may also lead to side effects such as nausea, vomiting, edema, and diarrhea, which should be monitored by healthcare providers. It is crucial for patients to discuss their full medical history and any potential interactions with other medications before starting this treatment. Regular follow-up appointments are recommended to assess the effectiveness of the therapy and manage any adverse reactions. With its targeted approach, Crizalk 250 mg capsules represent an important advancement in the treatment of specific lung cancers, helping patients navigate their diagnosis with a more personalized strategy.
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Pharmaceutical Capsules' category



Back to top